In a study of two EMS agencies, researchers found an increase in the variability of chest compression quality for the rate and depth of compressions during the ground transport of cardiac arrest patients, according to a study presented in January at the 2010 National Association of EMS Physicians (NAEMSP) conference in Phoenix, Ariz.

CureDM and pharmacuetical company Sanofi-Aventis have signed an agreement for the licensing of CureDMs Pancreate, an islet neogenesis agent for the treatment of type 1 and 2 diabetes.

To prevent blood clots during therapeutic hypothermia, researchers have developed what may be the first drug activated by cool temperatures and turned off by warm ones, according to research presented April 9 at the American Heart Association's 2010 Arteriosclerosis, Thrombosis and Vascular Biology annual conference in San Fransisco.

When bioprosthetic valves fail, transcatheter valve-in-valve implantation may be a viable option used to mend aortic, pulmonary, mitral and tricuspid tissue valves, based on a study published in Circulation on April 12.

Bristol-Myers Squibb (BMS) has selected Charles Bancroft to serve as its permanent chief financial officer (CFO).

At Columbia University Medical Center in New York City, prior to the overhaul of its previous Clinical Trial Management Solution, the facility held minimal oversight over its payment cycle and information on sponsored clinical trials was not available and unaccounted for, said Susan Adler, research applications administer of the clinical trials office at Columbia during a webinar yesterday sponsored by StudyManager.

In the twelve months before July 1, 2009, 85 pharmaceutical manufacturers paid about $2.6 million to Vermont doctors, hospitals, universities and others for the purpose of marketing their drugs. This was a drop from nearly $3 million the previous fiscal year.

The 11th Circuit Appellate Court has upheld a lower court decision to grant AstraZeneca's summary judgment and dismiss the first product liability case that had been prepared for trial in the quetiapine (Seroquel) federal Multi-District Litigation.